Singapore Genetic Testing Market to 2032
Overview
The Singapore Genetic Testing Market is expected to reach a 1,087.41 USD Million by 2032 and is projected to grow at a CAGR of 23.48% from 2025 to 2032.
Revenue, 2024 (USD Million)
323.58
Forecast, 2032 (USD Million)
1,087.41
CAGR, 2024 - 2032
23.48%
Report Coverage
Singapore
Singapore Genetic Testing Market 2018-2032 USD Million
Singapore Genetic Testing Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 323.58 USD Million
- Projected Market Size (2032): 1,087.41 USD Million
- CAGR (2025-2032): 23.48%
Key Findings of Singapore Genetic Testing Market
- The Singapore Genetic Testing Market was valued at 323.58 USD Million in 2024.
- The Singapore Genetic Testing Market is likely to grow at a CAGR of 23.48% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Cancer in Diseases Segment accounted for the largest share of the market with a revenue of 212.03 USD Million
- The fastest growing segment Diagnostic Testing in Type Segment grew Fastest with a CAGR of 25.95% during the forecast period from 2024 to 2032.
Singapore Genetic Testing Market Scope
Singapore Genetic Testing Market Segmentation & Scope
Type
- Other Types
- Carrier Testing
- Predictive and Presymptomatic Testing
- New Born Screening
- Prenatal Testing
- Diagnostic Testing
Technology
- Others
- Fluorescence In Situ Hybridization (FISH)
- Microarrays
- Whole Genome Sequencing
- DNA Sequencing (NGS-Based Testing)
- Polymerase Chain Reaction
Diseases
- Others
- Cystic Fibrosis
- Huntington's Disease
- Duchenne Muscular Dystrophy
- Fragile X Syndrome
- Rare Genetic Disorder
- Thalassemia
- Sickle Cell Anemia
- Cancer
End User
- Private Laboratories
- Laboratory Service Providers
- Private Clinics
- Diagnostic Centers
- Clinics
- Hospitals
Singapore Genetic Testing Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 323.58 USD Million |
| Market Value in 2032 | 1,087.41 USD Million |
| CAGR (2025-2032) | 23.48% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Type,Technology,Diseases,End User |
Regional Insights:
-
Leading Market (2024-2032): Singapore, leading in terms of revenue 323.58 USD Million in 2024
- Key Country: Singapore, leading in terms of revenue with value of 323.58 USD Million in 2024.
Segments and Scope
-
Singapore Genetic Testing Market to 2032, By Type
- Diagnostic Testing is the largest segment in Singapore Genetic Testing Market to 2032 with a revenue of 141.61 USD Million in the year 2024.
- Diagnostic Testing is the Fastest growing segment in Singapore Genetic Testing Market to 2032 with a Growth rate of 25.95 % in forecast period 2025-2032.
-
Singapore Genetic Testing Market to 2032, By Technology
- Polymerase Chain Reaction is the largest segment in Singapore Genetic Testing Market to 2032 with a revenue of 153.40 USD Million in the year 2024.
- Polymerase Chain Reaction is the Fastest growing segment in Singapore Genetic Testing Market to 2032 with a Growth rate of 25.52 % in forecast period 2025-2032.
-
Singapore Genetic Testing Market to 2032, By Diseases
- Cancer is the largest segment in Singapore Genetic Testing Market to 2032 with a revenue of 212.03 USD Million in the year 2024.
- Cancer is the Fastest growing segment in Singapore Genetic Testing Market to 2032 with a Growth rate of 24.64 % in forecast period 2025-2032.
-
Singapore Genetic Testing Market to 2032, By End User
- Hospitals is the largest segment in Singapore Genetic Testing Market to 2032 with a revenue of 135.40 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in Singapore Genetic Testing Market to 2032 with a Growth rate of 25.84 % in forecast period 2025-2032.
Singapore Genetic Testing Market Company Share Analysis
| Company Name |
|
||
| PerkinElmer Inc. | |||
| Illumina, Inc. | |||
| Thermo Fisher Scientific Inc. | |||
| Cepheid | |||
| Fulgent Genetics | |||
Singapore Genetic Testing Market Geographical Sales Distribution, 2018-2032 USD Million
Singapore Genetic Testing Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Singapore Genetic Testing Market is segmented based on Segmentation Type,Technology,Diseases,End User.
Singapore Genetic Testing Market was valued at USD 323.58(Revenue in USD Million) in 2021.
Singapore Genetic Testing Market is projected to grow at a CAGR of 23.48% during the forecast period of 2024 to 2032.
The Cancer segment is expected to dominate the Singapore Genetic Testing Market, holding a largest market share of 212.03 USD Million in 2024
Singapore Genetic Testing Market Scope
Singapore Genetic Testing Market Segmentation & Scope
Type
- Other Types
- Carrier Testing
- Predictive and Presymptomatic Testing
- New Born Screening
- Prenatal Testing
- Diagnostic Testing
Technology
- Others
- Fluorescence In Situ Hybridization (FISH)
- Microarrays
- Whole Genome Sequencing
- DNA Sequencing (NGS-Based Testing)
- Polymerase Chain Reaction
Diseases
- Others
- Cystic Fibrosis
- Huntington's Disease
- Duchenne Muscular Dystrophy
- Fragile X Syndrome
- Rare Genetic Disorder
- Thalassemia
- Sickle Cell Anemia
- Cancer
End User
- Private Laboratories
- Laboratory Service Providers
- Private Clinics
- Diagnostic Centers
- Clinics
- Hospitals
Frequently Asked Questions
The Singapore Genetic Testing Market is segmented based on Segmentation Type,Technology,Diseases,End User.
Singapore Genetic Testing Market was valued at USD 323.58(Revenue in USD Million) in 2021.
Singapore Genetic Testing Market is projected to grow at a CAGR of 23.48% during the forecast period of 2024 to 2032.
The estimated market value of the Singapore Genetic Testing Market for final year is USD 1,087.41 (USD Million).
Singapore Genetic Testing Market Company Profiling
Frequently Asked Questions
The Singapore Genetic Testing Market is segmented based on Segmentation Type,Technology,Diseases,End User.
Singapore Genetic Testing Market was valued at USD 323.58(Revenue in USD Million) in 2021.
Singapore Genetic Testing Market is projected to grow at a CAGR of 23.48% during the forecast period of 2024 to 2032.
The estimated market value of the Singapore Genetic Testing Market for final year is USD 1,087.41 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.